Art
J-GLOBAL ID:201702236980717325   Reference number:17A0339039

LOW-DOSE ESTRAMUSTINE PHOSPHATE MONOTHERAPY IN CASTRATION-RESISTANT PROSTATE CANCER PATIENTS

去勢抵抗性前立腺癌に対する低用量リン酸エストラムスチン単独療法の検討
Author (11):
Material:
Volume: 63  Issue:Page: 57-62  Publication year: Feb. 28, 2017 
JST Material Number: F0649A  ISSN: 0018-1994  CODEN: HIKYAJ  Document type: Article
Article type: 原著論文  Country of issue: Japan (JPN)  Language: JAPANESE (JA)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0339039&from=J-GLOBAL&jstjournalNo=F0649A") }}
JST classification (3):
JST classification
Category name(code) classified by JST.
Clinical application of antitumor(=antineoplastic)drugs  ,  Drug therapy(=pharmacotherapy)for tumors  ,  Urogenital tumors(=neoplasms) 
Substance index (1):
Substance index
Chemical Substance indexed to the Article.
Reference (7):
  • Ravery V, Fizazi K, Oudard S, et al. : The use of estramustine phosphate in the modern management of advanced prostate cancer. BJU Int 108: 1782-1786, 2011
  • Pienta KJ, Redman B, Hussain M, et al. : Phase II evaluation of oral estramustine and oral etoposide in hormone-refractory adenocarcinoma of the prostate. J Cell Biochem 12 : 2005-2012, 1994
  • Petrylak DP, Tangen CM, Hussain MH, et al. : Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate-cancer. N Engl J Med 351: 1513-1520, 2004
  • Matsumoto K, Tanaka N, Hayakawa N, et al. : Efficacy of estramustine phosphate sodium hydrate (EMP) monotherapy in castration-resistant prostate cancer patients : report of 102 cases and review of literature. Med Oncol 30: 717-723, 2013
  • Inoue T, Ogura K, Kawakita M, et al. : Effective and safe administration of low-dose estramustine phosphate for castration-resistant prostate cancer. Clin Genitourin Cancer 14 : e9-e17, 2016
more...
Terms in the title (4):
Terms in the title
Keywords automatically extracted from the title.

Return to Previous Page